Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

60.30
+1.111.88%
Post-market: 60.28-0.0200-0.03%19:55 EST
Volume:2.20M
Turnover:132.32M
Market Cap:7.24B
PE:-11.78
High:61.29
Open:58.85
Low:58.05
Close:59.19
52wk High:64.13
52wk Low:29.31
Shares:120.00M
Float Shares:119.09M
Volume Ratio:1.31
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1182
EPS(LYR):-5.2646
ROE:-572.15%
ROA:-24.87%
PB:-19.62
PE(LYR):-11.45

Loading ...

Cytokinetics (CYTK) Gets a Buy from Evercore ISI

TIPRANKS
·
Yesterday

Strategic Positioning and Launch Readiness Propel Cytokinetics to ‘Buy’ Rating

TIPRANKS
·
Yesterday

Earnings Flash (CYTK) Cytokinetics Posts Q3 Loss $2.55 vs. FactSet Est of $1.57 Loss

MT Newswires Live
·
Yesterday

Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens

Reuters
·
Yesterday

Cytokinetics Q3 EPS $(2.25) Misses $(1.57) Estimate, Sales $1.936M Miss $3.556M Estimate

Benzinga
·
Yesterday

BRIEF-Cytokinetics Q3 Basic EPS USD -2.55

Reuters
·
Yesterday

Cytokinetics Reports Q3 Revenue of $1.9 Million

Reuters
·
Yesterday

Cytokinetics Q3 Net Income USD -306.178 Million

THOMSON REUTERS
·
Yesterday

Cytokinetics Faces Investor Class Action Over Securities Fraud Allegations

Reuters
·
Yesterday

Cytokinetics EVP Research & Development Fady Ibraham Malik Reports Disposal of Common Shares

Reuters
·
Nov 05

Cytokinetics to Participate in November Investor Conferences

GlobeNewswire
·
Nov 05

Cytokinetics (CYTK): Reassessing Valuation After Lawsuit Reveals Regulatory Risks for Key Heart Drug

Simply Wall St.
·
Nov 05

Cytokinetics Unveils New Data on Aficamten and Metoprolol in Hypertrophic Cardiomyopathy Trial

Reuters
·
Oct 31

Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025

THOMSON REUTERS
·
Oct 31

Cytokinetics CEO Makes Significant Stock Sale!

TIPRANKS
·
Oct 31

Cytokinetics CEO Robert I. Blum Reports Sale of Common Shares

Reuters
·
Oct 31

Cytokinetics Director Makes a Bold Move with Stock Sale

TIPRANKS
·
Oct 28

Director Wendell Wierenga Reports Disposal of Cytokinetics Incorporated Common Shares

Reuters
·
Oct 28

Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma

TIPRANKS
·
Oct 25

Does Litigation Over FDA Risk Disclosures Alter the Bull Case for Cytokinetics (CYTK)?

Simply Wall St.
·
Oct 24